Cadrenal Therapeutics (CVKD) Treasury Shares (2022 - 2026)
Cadrenal Therapeutics (CVKD) posted Treasury Shares of $1.0 million for Q1 2026, little changed sequentially from $1.0 million in Q4 2025, and up 69.52% YoY from $615940.0 in Q1 2025.
Cadrenal Therapeutics (CVKD) Treasury Shares (2022 - 2026) Analysis & Trends
Cadrenal Therapeutics has reported Treasury Shares for 5 years, with the latest figure at $1.0 million in Q1 2026.
- Quarterly Treasury Shares rose 69.52% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 69.52% YoY) and the FY2025 annual result came in at $1.0 million, up 69.52% from the prior year.
- Treasury Shares steadied at $1.0 million in Q1 2026 per CVKD's latest filing, from $1.0 million in the prior quarter.
- Over five years, Treasury Shares peaked at $1.0 million in Q4 2025 and troughed at $311653.0 in Q3 2024.
- A 5-year average of $675520.8 and a median of $615940.0 in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares changed 0.0% in 2024, then surged 97.64% in 2025.
- Over 5 years, Treasury Shares stood at $600000.0 in 2022, then rose by 2.66% to $615940.0 in 2023, then changed by 0.0% to $615940.0 in 2024, then jumped by 69.52% to $1.0 million in 2025, then changed by 0.0% to $1.0 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $1.0 million, $1.0 million, and $615940.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Cadrenal Therapeutics | 4.59 Mn | 2.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.60 Mn |
| Jun 30, 2026 | 4.60 Mn |
| Mar 31, 2026 | 1.04 Mn |
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 615,940.00 |
| Sep 30, 2025 | 615,940.00 |
| Jun 30, 2025 | 615,940.00 |
| Jun 30, 2025 | 615,940.00 |
| Mar 31, 2025 | 615,940.00 |
| Mar 31, 2025 | 615,940.00 |
| Dec 31, 2024 | 615,940.00 |
| Dec 31, 2024 | 615,940.00 |
| Sep 30, 2024 | 311,653.00 |
| Sep 30, 2024 | 311,653.00 |
| Dec 31, 2023 | 615,940.00 |
| Dec 31, 2023 | 615,940.00 |
| Dec 31, 2022 | 600,000.00 |
| Dec 31, 2022 | 600,000.00 |